Bioliberty, an Edinburgh, Scotland, UK-based technology startup advancing a soft robotic glove which can restore upper limb mobility in patients following a stroke, raised £2.2m in funding.
The round was led by Archangels, with participation from Eos Advisory, Old College Capital and Hanna Capital SEZC.
The company intends to use the capital to complete development of the trial product and finalize the development of its platform, as well as to fund the business through obtaining FDA approval and early commercial engagement in the US with rehabilitation clinics.
Co-founded in 2020 by Rowan Armstrong (CEO), Conan Bradley (Chief Design), Ross O’Hanlon (CTO) and Shea Quinn (COO), Bioliberty has created the Lifeglov – a soft robotic glove which offers rehabilitation for both the closing and opening strength of the hand. The glove monitors key metrics related to upper limb mobility and can show improvement as the patient progresses through their rehab.
The Lifeglov is accompanied by a Digital Therapy Platform, which provides the patient with tailored exercises to help develop natural hand strength. For stroke survivors, the glove helps carry out rehabilitation from the home. For Occupational Therapists, the glove is a tool to help manage their patients remotely and improve patient outcomes.
The company, which currently employs a team of 7, is currently preparing for its US launch in 2024.
FinSMEs
04/04/2023